Vanguard Group Inc Immunity Bio, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 20,344,554 shares of IBRX stock, worth $54.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,344,554

Previous 17,328,229 17.41%

Holding current value

$54.1 Million

Previous $44.4 Million 38.05%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$2.32 - $3.9 $7 Million - $11.8 Million	3,016,325 Added 17.41%	20,344,554 $61.2 Million
Q4 2024 Feb 11, 2025	BUY	$2.56 - $6.17 $1.09 Million - $2.63 Million	425,713 Added 2.52%	17,328,229 $44.4 Million
Q3 2024 Nov 13, 2024	BUY	$3.32 - $6.7 $10.2 Million - $20.6 Million	3,070,720 Added 22.2%	16,902,516 $62.7 Million
Q2 2024 Aug 13, 2024	BUY	$4.82 - $9.15 $1.41 Million - $2.67 Million	292,206 Added 2.16%	13,831,796 $87.4 Million
Q1 2024 May 10, 2024	BUY	$3.23 - $6.17 $681,739 - $1.3 Million	211,065 Added 1.58%	13,539,590 $72.7 Million
Q4 2023 Feb 14, 2024	SELL	$1.25 - $5.21 $1.68 Million - $7.02 Million	-1,347,162 Reduced 9.18%	13,328,525 $66.9 Million
Q3 2023 Nov 14, 2023	BUY	$1.29 - $3.1 $5.6 Million - $13.5 Million	4,342,386 Added 42.02%	14,675,687 $24.8 Million
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $3.13 Million - $13.1 Million	2,047,343 Added 24.71%	10,333,301 $28.7 Million
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $41,461 - $146,803	30,712 Added 0.37%	8,285,958 $15.1 Million
Q4 2022 Feb 10, 2023	BUY	$4.35 - $6.77 $764,316 - $1.19 Million	175,705 Added 2.17%	8,255,246 $41.9 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $2.03 Million - $3.58 Million	557,164 Added 7.41%	8,079,541 $40.2 Million
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $981,499 - $2.25 Million	366,231 Added 5.12%	7,522,377 $28 Million
Q1 2022 May 13, 2022	BUY	$5.05 - $7.53 $88,925 - $132,595	17,609 Added 0.25%	7,156,146 $40.1 Million
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $608,271 - $1.09 Million	107,279 Added 1.53%	7,138,537 $43.4 Million
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $13.5 Million - $21 Million	1,471,235 Added 26.46%	7,031,258 $68.5 Million
Q2 2021 Aug 13, 2021	BUY	$13.41 - $22.4 $74.6 Million - $125 Million	5,560,023 New	5,560,023 $79.4 Million

Others Institutions Holding IBRX

# of Institutions

239

Shares Held

79.9M

Call Options Held

1.08M

Put Options Held

2.73M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.06B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Immunity Bio, Inc. Transaction History